Adcentrx Therapeutics logo

Adcentrx Therapeutics Funding & Investors

Adcentrx is a biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases. By combining the targeting precision of biologics and the disease fighting power of small molecule payloads, Adcentrx strives to develop next generation targeted therapies for improving patient treatment options.

adcentrx.com

Total Amount Raised: $101,000,000

Adcentrx Therapeutics Funding Rounds

  • Series A

    $51,000,000

    Series A Investors

    Eight Roads Ventures
    Trinity Innovation Fund
    F-Prime
    LIGHTHOUSE
    Delta Capital
    ABio-X
    Quan Capital
    Partners Investment
  • Series A

    $50,000,000

    Series A Investors

    C-Bridge Capital
    Zoo Capital
    CBC Group
Funding info provided by Diffbot.